Sglt-2 Inhibitors And Glp-1 Receptor Agonists For Nephroprotection And Cardioprotection In Patients With Diabetes Mellitus And Chronic Kidney Disease. A Consensus Statement By The Eureca-M And The Diabesity Working Groups Of The Era-Edta (Vol 34, Gfy407, 2019)